Padmos, I.

patient response t-cell vaccine study vaccination assay t-cell responses trial antigen elispot interruption infection control count value treatment t-cell count dendritic nef-specific t-cell responses t-cell counts number therapy t cells treatment interruption analysis dc-based time points electroporated phase virus result proliferation peptide antiretroviral hiv -1-infected patients antiretroviral therapy immunol autologou immunotherapy nef-specific hiv infection event dc-based elispot regression protein dc-based elispot assay peptide-based elispot assay proliferative vaccine-specific t-cell responses -1-infected ifn -γ production dendritic cells cart resumption hiv-infected patients method increase laboratory point allard disease brussel cfse proliferation assays 17 patients sfu /million pbmcs change regression analysis leukapheresi study entry hiv-specific vaccine antigens immunization nadir cd 4 plasma administration resumption figure immunodeficiency activation group